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VAP proteins (human VAPB/ALS8, Drosophila
VAP33, and C. elegans VPR-1) are homologous
proteins with an amino-terminal major sperm pro-
tein (MSP) domain and a transmembrane domain.
The MSP domain is named for its similarity to the
C. elegans MSP protein, a sperm-derived hormone
that binds to the Eph receptor and induces oocyte
maturation. A point mutation (P56S) in the MSP do-
main of human VAPB is associated with Amyotrophic
lateral sclerosis (ALS), but the mechanisms underly-
ing the pathogenesis are poorly understood. Here
we show that the MSP domains of VAP proteins are
cleaved and secreted ligands for Eph receptors. The
P58S mutation in VAP33 leads to a failure to secrete
theMSP domain as well as ubiquitination, accumula-
tion of inclusions in the endoplasmic reticulum, and
an unfolded protein response. We propose that VAP
MSP domains are secreted and act as diffusible hor-
mones for Eph receptors. This work provides insight
into mechanisms that may impact the pathogenesis
of ALS.
INTRODUCTION
The mechanisms that underlie Amyotrophic lateral sclerosis
(ALS) are poorly understood. ALS is associated with the dysfunc-
tion or death of motor neurons in the motor cortex, brain stem,
and spinal cord. About 10%–15% of all ALS cases are familial,
whereas 85%–90% are sporadic (Boille´e et al., 2006; Bruijn
et al., 2004). The most common form of familial ALS is caused
by mutations in superoxide dismutase 1 (SOD1). Recently, Nish-
imura et al. (2004) identified another gene, ALS8, that causes fa-
milial ALS. This gene encodes the VAMP (synaptobrevin)-associ-
ated protein B (VAPB). Lesions in SOD1 and ALS8 have beenshown to cause a wide variety of symptoms that typically include
motor neuron death, but vary widely in the age of onset, the
speed of progression, and the motor neuron populations that
are affected. For example, a single amino acid change in ALS8
(P56S) causes typical ALS, atypical slowly progressive ALS,
and spinal muscular atrophy (SMA) with an age of onset between
25 and 52 years and a speed of progression between 2 and 30
years (Nishimura et al., 2004). The cause of this variation may
be due to genetic modifiers, partial redundancy, or environment.
VAPB is closely related to VAPA, which has been shown to as-
sociate with the cytoplasmic face of the endoplasmic reticulum
(ER) and the Golgi apparatus (Kaiser et al., 2005; Skehel et al.,
2000; Soussan et al., 1999). Human VAPB (hereafter named
hVAP) protein is about 30 kDa and has homologs in C. elegans
(VPR-1),Drosophila (VAP33-A, hereafter named dVAP) (Pennetta
et al., 2002), and numerous other species, including yeast
(Scs2p) (Kagiwada and Zen, 2003). VAPs consist of an amino
(N)-terminal domain of about 125 residues called the major
sperm protein (MSP) domain, which is conserved among all
VAP family members (Nishimura et al., 1999; Weir et al., 1998)
(Figure 1A). The central region is predicted to form a coiled-coil
motif. The hydrophobic carboxy (C)-terminus acts as a mem-
brane anchor. The MSP domain is named for its similarity to
nematode MSPs, the most abundant proteins in nematode
sperm (Bottino et al., 2002). MSP and VAP MSP domains fold
into evolutionarily conserved immunoglobulin-type seven-
stranded b sandwiches (Baker et al., 2002; Kaiser et al., 2005),
suggesting a common function.
The main difference between VAPs and MSP is their proposed
functions. C. elegans MSPs do not contain a coiled-coil motif or
a transmembrane domain (Ward et al., 1988). MSPs have an in-
tracellular cytoskeletal function, which depends on their ability to
polymerize in the absence of actin or myosin (Bottino et al., 2002)
and an extracellular signaling function during fertilization (Miller
et al., 2001). MSP is secreted from the sperm cytosol into the re-
productive tract by an unconventional process (Kosinski et al.,
2005). Extracellular MSP directly binds to the VAB-1 Eph recep-
tor and other yet-to-be-identified receptors on oocyte andCell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc. 963
Figure 1. VAP Localization
(A) The structure of VAPs. Note that VAPs form dimers.
(B and C) MARCM analysis showing the specificity of rabbit anti-dVAP antibody. A portion of the wing-imaginal disc stained with anti-dVAP antibody (Rb92). GFP
marks the mutant region (B). Single channel view of (B) showing only anti-dVAP (C).
(D–I) dVAP partially colocalizes with Spectrin. Salivary gland (D–F) and wing-imaginal disc (G–I) of CS flies.ovarian sheath cell surfaces (Corrigan et al., 2005; Govindan
et al., 2006; Miller et al., 2003). MSP induces oocyte maturation,
which prepares oocytes for fertilization and embryogenesis, and
sheath contraction (Miller et al., 2001).
The Eph receptors are an evolutionarily conserved class of re-
ceptor tyrosine kinases that bind to membrane-attached ligands
called Ephrins (Palmer and Klein, 2003). Ephrins act in parallel to
gap junctions to inhibit oocyte maturation, and MSP antagonizes
this inhibitory circuit (Govindan et al., 2006; Miller et al., 2003;
Whitten and Miller, 2007). MSP induces activation of the MAP ki-
nase and Ca2+/calmodulin-dependent protein kinase II cascades
(Corrigan et al., 2005; Miller et al., 2001) as well as reorganization
of the oocyte microtubule cytoskeleton (Harris et al., 2006).
The biological function of VAPs is not well understood. Yeast
Scs2p is involved in phosphatidylinositol-4-phosphate synthesis964 Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc.and ceramide transport (Brickner and Walter, 2004; Kagiwada
and Zen, 2003). VAPs have been reported to associate with the
ER (Amarilio et al., 2005; Kaiser et al., 2005; Soussan et al.,
1999). Overexpression of hVAP in human cells affects the struc-
tural integrity of the ER (Teuling et al., 2007) through interaction
with Nir (N-terminal domain-interacting receptor) proteins (Amar-
ilio et al., 2005). VAPs also interact with oxysterol-binding protein
(OSBP) and ceramide transfer protein. These interactions are
each mediated through FFAT (two phenylalanines in an acidic
tract) domains (Amarilio et al., 2005; Kaiser et al., 2005; Loewen
and Levine, 2005). Taken together, the results suggest that VAPs
might play a role in fatty acid metabolism (Perry and Ridgway,
2006; Wang et al., 2005).
To further define the role of VAPs, we have been characterizing
Drosophila dVAP (Pennetta et al., 2002). dVAP modulates the
number and size of neuromuscular junction (NMJ) boutons. Loss
of dVAP disrupts the presynaptic microtubule architecture (Pen-
netta et al., 2002) and causes an increase in miniature excitatory
junctional potential (mEJP) size as well as an increase in postsyn-
aptic glutamate receptor clustering (Chai et al., 2008).
Here, we present evidence that VAP MSP domains are se-
creted ligands for Eph receptors. We propose that secreted
MSP domains function as trophic factors by binding to Eph re-
ceptors and other cell-surface receptors. The P56S mutation
that causes ALS8 (P58S in dVAP) induces insoluble aggregates
that are ubiquitinated in flies. The mutation also leads to an accu-
mulation of mutant and wild-type protein in the ER, an unfolded
protein response (UPR), and a failure to secrete the MSP domain.
Collectively, our results suggest that P56S affects a cell-auto-
nomous pathway involving the ER and UPR as well as a cell non-
autonomous pathway involving Eph receptor signaling.
RESULTS
The N-Terminal Portion of dVAP Is Secreted
We previously generated guinea pig polyclonal antibodies
against dVAP, which specifically detect the protein on western
blots (Pennetta et al., 2002). Although these antibodies (GP33
or GP36) detect overexpressed dVAP, the presence of some im-
munofluorescence signals in dVAP null mutant tissue (dVAPD20
or dVAPD488) suggests that they recognize a nonspecific compo-
nent (data not shown). We generated new antisera against dVAP
(Rb92) and confirmed antibody specificity (Figures 1B and 1C).
To assess the cellular dVAP distribution, we costained fly tissues
with anti-dVAP and cellular markers. We find that dVAP is asso-
ciated with the ER in wing-imaginal disc cells (data not shown)
and salivary gland cells (Figures S1A–S1C). dVAP is also local-
ized to the cell membrane or just beneath the cell membrane
based on its partial colocalization with spectrin (Pesacreta
et al., 1989) (Figures 1D–1I). In addition, we observed numerous
punctae (arrows in Figure 1H) in wild-type tissue, which neither
colocalize with Spectrin nor Boca, an ER marker (Figure 1I;
data not shown). These punctae are most often found near cell
boundaries, suggesting that they are in the extracellular space.
To determine if dVAP is present extracellularly, we used proto-
cols for distinguishing between extracellular and intracellular an-
tigens in wing discs (Seto and Bellen, 2006; Strigini and Cohen,
2000). Extracellular dVAP is found in wild-type discs (Figure 2A)
but is absent indVAP null mutant discs (Figure 2B). These data in-
dicate that a portion of dVAP or the whole protein can be secreted.
There are at least two possible alternatives. The wing cells re-
verse dVAP polarity such that it remains membrane anchored
but the N terminus is extracellular. Alternatively, dVAP is cleaved
intracellularly, and a portion is secreted. To determine which por-
tion of dVAP is extracellular, we generated transgenic flies carry-
ing the dVAP cDNA tagged with an N-terminal FLAG tag and a
C-terminal HA tag. This UAS construct is able to rescue the le-
thality associated with dVAP loss, indicating that it is functional
(data not shown). To examine the localization of the tagged pro-
tein, we used the dpp-GAL4 driver (Figure 2C). Anti-FLAG anti-
body staining without membrane permeabilization shows that
the N-terminal portion of dVAP is extracellular (Figures 2D and
2E), whereas staining with anti-HA antibody (Figures 2D and2F) shows that the C-terminal portion is intracellular. We then in-
cubated the live discs expressing FLAG-dVAP-HA protein with
anti-FLAG antibody, fixed and permeabilized the cells, and incu-
bated the discs with anti-HA antibody. As shown in Figures 2G–
2I, the N-terminal part of dVAP is more broadly distributed than
the C-terminal portion, typically extending from 1–3 cells beyond
the dpp-GAL4 expressing cells, which indicates that the N-ter-
minal portion is secreted and diffuses away. In summary, our
data provide strong evidence that the dVAP protein is cleaved
and that an N-terminal portion is secreted.
The MSP Domain of dVAP Is Cleaved
Western blots should allow identification of the processed forms
of the protein. We extracted proteins from larvae expressing
FLAG-dVAP-HA and performed western blotting with anti-
dVAP (GP33) and anti-FLAG. The size of the full-length protein
is about 33 kDa. Extracts from wild-type third-instar larvae
(Figure 2J; Canton S (CS), left) show a broad set of bands around
33 kDa as well as less abundant smaller-sized bands. At least
four different proteins (235 aa, 238 aa, and two different 269 aa
proteins, which all seem to differ in the coiled-coil domain), can
be derived from the dVAP locus (FlyBase ID; FBgn0029687).
These proteins migrate in the 28–33 kDa range, whereas the
17 kDa band is probably a cleavage product. None of these
proteins is present in dVAP null mutants (data not shown).
To determine the cleavage profile of the overexpressed FLAG-
dVAP-HA protein we probed the same blot for the N-terminal
FLAG tag. We observe no staining in wild-type controls (CS)
and dVAP null mutant animals (not shown). However, we ob-
serve 22–37 kDa bands as well as multiple bands in the 13–18
kDa range (Figure 2J). Since we expressed a single isoform of
FLAG-dVAP-HA (around 38 kDa), many of the bands labeled
with anti-FLAG must be cleavage products. Probing the blot
with the HA tag confirms that the FLAG-containing products
are uniquely N terminal. The size of the N-terminal cleavage
product indicates that it must contain most or all of the MSP do-
main (about 125 amino acids). The bands revealed by anti-HA
(10–15 kDa) correspond to multiple cleavage products. In sum-
mary, our data suggest that the MSP domain of the dVAP protein
is cleaved from the transmembrane domain.
To determine if secretion of the MSP domain is observed in hu-
mans, we examined the expression of hVAP in flies, human leu-
kocytes, and human serum. The anti-hVAP antibody was raised
against the full-length (30 kDa) human protein (Amarilio et al.,
2005). This antibody does not crossreact with the Drosophila
protein (Figure 2K; control, lane C155/+). When hVAP is ex-
pressed in flies, we detect full-length protein and cleavage prod-
ucts. In human leukocytes, we detect the full-length protein as
well as additional 25 kDa and 18 kDa bands (Figure 2K, lane
WBC). In contrast, we only detect the 18 kDa band in human se-
rum (Figures 2K–2L, lane Serum; Figure S1D). Taken together,
our data indicate that VAP MSP domains are secreted and sug-
gest that the hVAP MSP domain is found in human serum.
P58S dVAP Fails To Be Secreted, Aggregates
in the Cytoplasm, and Is Ubiquitinated
In humans, the P56S mutation in hVAP causes ALS8 (Nishimura
et al., 2004). To better understand the nature of the mutation,Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc. 965
Figure 2. A Portion of VAP Is Secreted
(A and B) dVAP in the wing disc is localized extracellularly. Staining of a wing pouch of CS (A) and dVAP null mutant (DVAP) (B) with anti-dVAP antibody (Rb92)
without membrane permeabilization. Note that not all cells are decorated by dVAP.
(C) Pattern of expression of dpp-GAL4 in the wing-imaginal disc. Anterior is to the left, ventral is to the top. The square in the center corresponds to Figures 2D–2I.
(D–F) The N terminus but not the C terminus of dVAP is localized extracellularly. The wing disc expressing FLAG-dVAP-HA was costained with anti-FLAG and anti-
HA without permeabilization.
(G–I) The N-terminal portion of dVAP is distributed more widely than the C-terminal portion. The wing disc expressing FLAG-dVAP-HA was stained with anti-FLAG
extracellularly, and subsequently stained with anti-HA intracellularly (G). Total intra- and extracellular staining; (ex) extracellular staining only.
(J) The N-terminal region of dVAP is cleaved from the full-length protein. da-GAL4 was used to express FLAG-dVAP-HA ubiquitously. Extracts from CS and flies
expressing FLAG-dVAP-HA were immunoblotted with anti-dVAP (left panel), anti-FLAG (middle panel), and anti-HA (right panel).
(K) Truncated hVAP is expressed in human serum. Protein of wild-type flies and those expressing hVAP were extracted and immunoblotted with anti-hVAP
antibody (left panel). The extracts of human white blood cells and serum are immunoblotted with anti-hVAP antibody (right panel). Note that only the truncated
hVAP protein is expressed in the serum (arrow in right panel).
(L) hVAP is expressed in human serum of five different individuals. The extracts of human serum were immunoblotted with anti-hVAP antibody. * indicates non-
specific band (see Figure S1D).we generated a UAS-P58S dVAP construct, which corresponds
to the P56S mutation in hVAP. We examined the subcellular
localization of P58S dVAP and wild-type (WT) dVAP proteins
expressed ectopically in the wing disc under the control of the
dpp-GAL4 driver. As shown in Figures 3A and 3B, when the
cells are not permeabilized, we observe extracellular staining
of WT dVAP. However, little or no extracellular staining is ob-
served when P58S dVAP is overexpressed (Figures 3C and
3D). To further examine the effect of the mutation on secretion,
we overexpressed the WT and P58S dVAP MSP domains in S2
cells. As shown in Figure S2A, WT dVAP MSP, but not mutant
dVAP MSP, is present in the conditioned medium. These data966 Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc.indicate that the P58S mutation prevents secretion of the MSP
domain.
The staining of permeabilized wing disc cells with anti-dVAP
antibodies shows that the P58S mutation causes the dVAP pro-
tein to localize to intracellular aggregates (Figures 3E–3H). These
aggregates resemble cytoplasmic protein inclusions found in
ALS patients (Boille´e et al., 2006; Bruijn et al., 2004). To compare
the localization of WT and P58S in motor neurons, we expressed
the transgenes under control of C155- and C164-GAL4 in
a dVAP null mutant background. WT dVAP is present in the
cytoplasm and axons (Figures 3I, S2B, S2C, S2F, and S2G),
whereas P58S dVAP exhibits a very different profile with
Figure 3. The P58S Mutation Leads to a Failure to Secrete dVAP and Forms Ubiquitinated Inclusions
(A–D) The P58S mutation leads to a loss of the extracellular localization of dVAP. The wing discs expressing WT dVAP (A and B) and P58S dVAP (C and D) were
stained using the anti-dVAP (magenta) extracellular-staining protocol and subsequently stained with anti-DLG (green) upon permeabilization.
(E–H) The P58S mutation causes dVAP protein to be localized as intracellular inclusions. Wing discs expressing WT dVAP (E and F) and P58S dVAP (G and H).
(I–L) Expression of P58S dVAP causes ubiquitin-containing inclusions. Neurons expressing WT dVAP (I and J) or P58S dVAP (K and L) were stained with anti-
dVAP (I and K) and anti-ubiquitin (J and L). The laser intensity was adjusted for the signals of overexpressed proteins. Hence, endogenous expression of
dVAP cannot be observed (Figures 3A–3L).
(M) The P58S mutation causes detergent-insoluble aggregates. Extracts of CS, null mutant (DVAP), and null mutant flies overexpressing WT or P58S dVAP were
immunoblotted with anti-dVAP. Detergent-soluble fractions (lanes 1–4); insoluble fractions (lanes 5–8).
(N) P58S dVAP is ubiquitinated. Anti-dVAP (GP33) was used to immunoprecipitate dVAP from extracts ofDVAP and flies expressing WT (C155>WTdVAP) or P58S
dVAP (C155 > P58SdVAP). Immunoblots of anti-ubiqutin (right top panel) and anti-dVAP (right bottom panel). Bracket, ubiquitin-positive high molecular weight
products; *, nonspecific signals.Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc. 967
Figure 4. P58S dVAP Protein Accumulates in the ER, Causes Morphological Changes in the ER, and Induces a UPR
(A–D00) Single motor neurons expressing FLAG-WT dVAP-HA probed with HA or FLAG antibodies. WT dVAP (A–A00 and C–C00) or P58S dVAP (B–B00 and D–D00)
and FLAG-WTdVAP-HA are expressed in motor neurons with the C164-GAL4 driver. Note that all motor neurons expressing P58S dVAP have protein
aggregates.
(E–F00) Boca is localized diffusely in the cytoplasm in flies expressing WT dVAP. In contrast, Boca is localized in inclusions in flies expressing P58S dVAP.
(G–H00) PDI-GFP is localized diffusely in the cytoplasm when WT dVAP is coexpressed in PDI-GFP transgenic flies. In contrast, PDI GFP is present in inclusions
when P58S dVAP is expressed.968 Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc.
numerous cytoplasmic punctae (Figures 3K, S2D, and S2E) and
axonal aggregates (Figures S2H and S2I).
To test whether P58S dVAP is ubiquitinated, we costained flies
expressing WT or P58S dVAP with anti-dVAP and anti-ubiquitin
antibodies. Expression of wild-type protein does not cause ubiq-
uitination (Figures 3I and 3J), whereas aggregates induced by
P58S dVAP expression stain positively with anti-ubiquitin anti-
bodies (Figures 3K and 3L). As shown in Figure 3M, these aggre-
gates are likely to contain insoluble P58S dVAP. The high molec-
ular weight ladder seen in lane 8 (bracket) is consistent with
ubiquitination. To confirm that P58S dVAP is ubiquitinated, we
performed immunoprecipitation (IP) assays to isolate dVAP pro-
tein from flies expressing WT or P58S dVAP. We immunoblotted
the IP products with anti-ubiquitin antibodies. As shown in
Figure 3N (bracket), the IP product from P58S dVAP, but not
WT dVAP, is positive for ubiquitin. In summary, P58S dVAP fails
to be secreted, is ubiquitinated, and accumulates in cytoplasmic
inclusions.
P58S dVAP Accumulates in and Disrupts the ER
and Induces an Unfolded Protein Response
VAPs are ER-associated proteins that can form homodimers and
heterodimers (Kaiser et al., 2005). To test whether P58S dVAP
can recruit wild-type dVAP to mutant inclusions, we first ex-
pressed FLAG-WT dVAP-HA and WT dVAP together in motor
neurons. As shown in Figures 4A–A00 and 4C–C00, we find that
FLAG-WT dVAP-HA is localized diffusely in the cytoplasm
when it is coexpressed with WT dVAP.
When we overexpress FLAG-WT dVAP-HA and P58S dVAP
together, we find that the tags are localized to inclusions (Figures
4B–4B00 and 4D–D00), indicating that WT dVAP is recruited into the
inclusions. To determine if other ER-associated proteins are
present in these inclusions, we costained flies expressing
P58S dVAP with anti-dVAP and anti-Boca, an ER marker (Culi
and Mann, 2003). As shown in Figures 4F and F0, Boca is present
in the inclusions. Similarly, protein-disulfide isomerase (PDI),
another ER marker (Herpers and Rabouille, 2004), is also present
in the inclusions (Figures 4H–H00). Transmission electron micros-
copy (TEM) of wing disc cells overexpressing WT or P58S
dVAP shows that mutant dVAP causes abnormalities in the ER
(Figures 4L–4N). Flies expressing P58S dVAP exhibit clusters
of aberrant electron-dense material (bracket in Figure 4N) that
is continuous with the rough ER (arrow) in numerous cells. In
summary, P58S dVAP recruits WT dVAP to cytosolic inclusions,
alters the distribution of ER markers, and affects ER structure.
We next tested whether P58S dVAP induces a UPR, which has
been documented in sporadic ALS as well as mutant SOD1
transgenic animals (Atkin et al., 2006; Kikuchi et al., 2006). To
evaluate the UPR, we assessed the expression of BiP/Hsc3,
a member of the Hsp70 chaperone family and a primary sensor
in the UPR (Elefant and Palter, 1999; Morris et al., 1997; Ryoo
et al., 2007). As shown in Figures 4O–4Q, adult brains overex-pressing P58S dVAP exhibit significantly higher levels of Hsc3
(see Figure S3 for detail and western blot). These data suggest
that P58S dVAP causes a UPR in vivo.
The Phenotypic Consequences of P58S
dVAP Overexpression
To assess the phenotypic consequences of P58S, we compared
overexpression of wild-type and mutant protein in three different
assays. First, presynaptic overexpression of the WT dVAP pro-
tein using the C155-GAL4 driver causes a significant increase
in bouton number (Pennetta et al., 2002), whereas overexpres-
sion of the P58S mutant dVAP (Figure S4A) does not cause a se-
vere overgrowth phenotype. Second, we compared the ability of
flies overexpressing mutant and wild-type protein in a flight as-
say. Overexpression of WT dVAP significantly reduces flight abil-
ity, whereas overexpression of P58S dVAP causes only a mild
phenotype (Figure S4B). These phenotypic differences are not
due to differences in transgene expression (Figure S4C).
Finally, we performed ultrastructural studies of the indirect
flight muscles. Wild-type control animals (Figures 5A and 5B)
display regular organization and uniform size of the myofibrils,
and each myofibril (arrow) is smooth and surrounded by mito-
chondria (arrowhead). When the WT dVAP protein is expressed
under the control of a neuronal driver (C155-GAL4) (Figures 5C
and 5D), we find severe defects in 7% of the myofibrils. We do
not observe these defects in wild-type controls and flies ex-
pressing P58S dVAP (Figures 5G–5H). In addition, the myofibrils
are much more heterogeneous (mean of SD = 0.61 ± 0.90, p <
0.01 when compared to the control animals) in size when WT
dVAP is overexpressed compared to when P58S is overex-
pressed (mean of SD = 0.33 ± 0.70, p < 0.05 when compared
to the control animals; Figures 5E and 5F). These results indicate
that overexpression of WT dVAP in neurons can cause muscle
defects and that P58S dVAP does not replicate the phenotypes
of overexpressed WT protein.
To determine the consequences of loss and overexpression of
dVAP in synaptic transmission, we compared the electrophysio-
logical properties of various animals. As shown in Figures S5A
and S5B, loss of function causes a moderate but significant in-
crease in excitatory junctional amplitude (EJP) and miniEJP
(mEJP), whereas overexpression of wild-type or P58S induces
a subtle reduction in EJP, which is however not significant (Fig-
ure S5C).
In summary, we have shown that the dVAP MSP domain is se-
creted and that WT dVAP overexpression can cause a cell-non
autonomous defect. The P58S mutation prevents secretion
and potentially affects other functions such that overexpression
of the mutant protein does not phenocopy that of wild-type
dVAP. P58S dVAP must retain some activity because overex-
pression of P58S dVAP in the nervous system (C155-GAL4) is
able to rescue the lethality associated with the null mutations
(data not shown) (Chai et al., 2008). Thus, P58S dVAP may be(L–N) TEM analysis of wing disc cells expressing WT or P58S dVAP with C5-GAL4, a wing-pouch driver. Note that flies expressing P58S dVAP (N) contain clus-
ters of aberrant electron-dense material (bracket) that is continuous with the rough ER (arrow). These clusters were commonly observed inC5>P58SdVAP (n = 3
flies) and were never observed in wild-type control cells (n = 3 flies).
(O–Q) Overexpression of P58S dVAP causes a UPR. Anti-Hsc3 and anti-Elav costaining of adult brains of control flies (O), flies expressing WT dVAP (P), or P58S
dVAP (Q).Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc. 969
secreted at very low levels or secretion may not be required for
all activities.
VAP MSP Domains Signal in an Extracellular
Environment
The C. elegans genome contains a single VAP homolog, called
F33D11.1 or VPR-1 (for VAP33-related). However, 28 loci
encode the sperm-specific MSPs, which are sperm-derived
hormones that induce oocyte maturation and ovarian sheath
contraction (Bottino et al., 2002; Yamamoto et al., 2006). When
sperm and MSP are absent, oocyte maturation and sheath con-
traction rates are very slow, preventing oocyte loss (McCarter
et al., 1999). Microinjecting purified, sperm-derived, or recom-
binant MSP into the reproductive tract (Figure 6A) promotes
oocyte maturation and sheath contraction (Miller et al., 2001).
These responses are identical to those induced by wild-type
sperm and are not induced by other sperm proteins, endoge-
nous bacterial proteins, or several commercially available hor-
mones (Corrigan et al., 2005; Miller et al., 2001).
Figure 5. Overexpression of P58S dVAP Does Not Pheno-
copy WT dVAP Overexpression
(A–F) TEM analysis of the dorsal ventral muscle (DVM) of flies over-
expressing various dVAPs in neurons. Control animals (A and B),
flies overexpressing neuronal WT dVAP (C and D), and P58S
dVAP (E and F). Five animals, > 30 muscles/animal were examined
of each genotype.
The primary sequences of VAP MSP domains and
MSPs are about 25% identical. If VAP MSP domains
are secreted ligands for conserved receptors, they
should be able to mimic the signaling activities of
MSPs. To test this prediction, we microinjected puri-
fied, recombinant VPR-1 MSP domain into gonads
lacking MSP and sperm (Figures 6A and 6B). As
shown in Figure 6B, VPR-1 MSP stimulates a strong
increase in oocyte maturation and sheath contrac-
tion rates over the same concentration range as MSP.
Microinjecting dVAP and hVAP MSP domains also
induces both responses (Figure 6B), suggesting that
all MSP domains can signal through a common mech-
anism(s). The hVAP P56S mutant functions similarly
to the wild-type protein in this assay, indicating that
this mutation does not affect signaling activity in
the worm gonad. We conclude that the C. elegans
MSP and VAP MSP domains have an evolutionarily
conserved extracellular-signaling activity.
VAPs and Eph Receptors Function in Common
Genetic Pathways
Previous studies indicate that sperm-derived MSPs
binds to the VAB-1 Eph receptors and unidentified re-
ceptors expressed in oocytes and sheath cells (Govin-
dan et al., 2006; Miller et al., 2003). We hypothesized
that VAP MSP domains also regulate Eph receptors,
which are widely expressed in fly, worm, and human
nervous systems (George et al., 1998; Palmer and
Klein, 2003). To test this hypothesis, we first sought
to determine whether VAPs are required for the same in vivo pro-
cesses as Eph receptors. Mutations in Eph receptors cause de-
fects in cell and axon guidance during development (Klein, 2004).
The Drosophila Eph receptor and its ligand Ephrin are required
for proper axon guidance of the mushroom body (MB) neurons.
Eph receptor and Ephrin mutations cause loss of a lobes (Boyle
et al., 2006). We found that dVAP null mutants and double mu-
tants (DVAP; DEph) lack a lobes in late pupae and adult brains
(Figures S6B and S6D; data not shown). The data indicate that
both dVAP and Eph receptors are required for a-lobe formation.
Overexpression of dVAP in neurons causes muscle defects in
flies, consistent with a signaling function (Figures 5A–5D). Eph
receptor mutants suppress the muscle phenotypes (variable di-
ameter of the myofibrils and myofibrillar degeneration) induced
by overexpressing dVAP (Figures S6A–S6E). Moreover, Ephrin
is present on muscles (Figures S6E–S6H). These data strongly
argue that the nonautonomous and toxic activity of overex-
pressed dVAP is mediated by Eph receptors. Other require-
ments for Eph receptor and Ephrin in flies have yet to be970 Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc.
determined, as the existing mutants are likely partial loss-of-
function mutations (Dearborn et al., 2002).
To examine the role of vpr-1 in C. elegans development, we
characterized a vpr-1 (tm1411) null mutant (Figures 6C and 6D).
Phenotypes associated with vpr-1 (tm1411) can be rescued by
transgenic expression of a fosmid containing vpr-1. Mutations
in the VAB-1 Eph receptor or Ephrin ligands cause incompletely
penetrant and variably expressed phenotypes during develop-
ment (Brenner, 1974; Chin-Sang et al., 1999, 2002; George
et al., 1998; Wang et al., 1999; Zallen et al., 1999). We found
that vpr-1 (tm1411) mutants, similar to vab-1 mutants, have in-
completely penetrant and variably expressed defects. Loss of
VPR-1, the Ephrin EFN-2, or VAB-1 causes defects in distal-tip
cell (DTC) migration (Figures 6E, and S7A–S7C). The DTC is a go-
nadal leader cell whose migration path can be monitored using
differential-interference contrast (DIC) microscopy or the lag-
2::GFP transgenic reporter, which expresses GFP in the DTC
(Blelloch et al., 1999). Analysis of vpr-1 and vab-1 double mu-
tants is consistent with these two genes acting in a common
pathway during DTC migration (Figures 6E and S7A).
VPR-1 and VAB-1 also function together to regulate the em-
bryonic migrations of ventral hypodermal cells undergoing en-
closure (Figure S7D and S7E) and amphid neurons (Figure 6F),
whose final positions in adults can be visualized with dye DiI
(Zallen et al., 1999). The amphids, as well as other head neurons,
often lie too far posterior in vpr-1 (tm1411) mutants compared to
the wild-type (Figures 6F and 6G). The amphids are sometimes
positioned too far anterior in vab-1 (dx31) mutants (Figure 6F).
Analysis of vpr-1 and vab-1 double mutants is consistent with
vpr-1 acting in vab-1-dependent and vab-1-independent mech-
anisms during embryogenesis (Figures 6F, S7D, and S7E). Taken
together, the data support the hypothesis that VAPs regulate
Eph receptor signaling in vivo.
VAP MSP Domains Bind to Eph Receptors
In the worm proximal gonad, the VAB-1 Eph receptor is ex-
pressed on oocyte and sheath cell surfaces (Figure 7A). VAB-1
and other MSP receptor sites can be visualized using fluores-
cein-labeled MSP (MSP-FITC) (Miller et al., 2003). MSP-FITC is
biologically active and binding can be outcompeted with a 25-
fold molar excess of unlabeled MSP (Figure 7B). To test whether
VAP MSP domains can bind to cell-surface receptors, we incu-
bated 200 nM FITC-labeled MSP domain conjugates with dis-
sected gonads. VPR-1, hVAP, and dVAP MSP domains bind to
oocyte and sheath cell plasma membranes in a pattern identical
to MSP-FITC (Figure 7B; data not shown). Preincubation of worm
gonads with a 25-fold molar excess of hVAP MSP domain out-
competes hVAP-FITC binding, indicating that binding is specific.
Moreover, MSP and hVAP likely bind to common receptors, as
MSP-FITC binding can be outcompeted with an excess of
hVAP (Figure 7B). These results strongly support the hypothesis
that VAP MSP domains bind to cell-surface receptors.
To test whether VAP MSP domains can directly bind to the Eph
receptor extracellular domain, we examined the interaction be-
tween VPR-1 MSP and VAB-1 Eph receptor. We produced
a V5-tagged VAB-1 ectodomain (VAB-1 Ex V5) in HEK293T cells.
We also expressed and purified a FLAG-tagged VPR-1 MSP
(VPR-1 MSP-FLAG) in bacterial cells and incubated the VPR-1MSP-FLAG and VAB-1 Ex V5 proteins to assess binding by
coimmunoprecipitation (coIP). As shown in Figure 7C, anti-
FLAG antibody coimmunoprecipitates the VAB-1 ectodomain
(top panel) together with VPR-1 MSP (bottom panel). Further-
more, the anti-V5 antibody coimmunoprecipitates the VPR-1
MSP (Figure 7D, bottom panel) together with the VAB-1 ectodo-
main (Figure 7D, top panel). These data indicate that VPR-1 MSP
is able to directly bind the VAB-1 ectodomain.
To examine the interaction between VAP MSP and Eph recep-
tor in mammals, we produced a His- and V5-tagged mouse
EphA4 ectodomain (mEphA4Ex-V5His) and His-tagged hVAP
MSP (hVAPMSP-His). We incubated mEphA4Ex-V5His together
with hVAPMSP-His proteins and performed coIP assays with the
V5 antibody. The V5 antibody is able to coimmunoprecipitate the
hVAP MSP protein (Figure 7E, top panel) together with the EphA4
ectodomain (Figure 7E, bottom panel), suggesting that hVAP
MSP binds to the EphA4 ectodomain directly.
Since VAP MSP can bind to the Eph receptor, VAP MSP might
compete with Ephrins for Eph receptor binding. To perform com-
petition experiments between hVAP MSP and Ephrin in mamma-
lian cells, we used conditioned medium from HEK293T cells ex-
pressing secreted hVAP MSP or the EphA4 ligand, EphrinB2. We
preincubated HEK293T cells expressing FLAG-tagged mouse
EphA4 (FLAG-mEphA4) with conditioned medium containing
hVAP MSP. Subsequently, we applied conditioned medium con-
taining Fc-tagged mouse EphrinB2 (mEphrinB2-Fc) to the cells.
After incubation, we retrieved mEphrinB2-Fc and EphA4 pro-
teins complexes and immunoblotted with the anti-FLAG anti-
body. As shown in the top panel of Figure 7F and quantified in
Figure 7G, hVAP MSP suppresses the binding of EphrinB2 to
EphA4 in a dose-dependent fashion. To confirm competition,
we incubated mEphA4Ex-V5His and hVAPMSP-His proteins to-
gether with EphrinB2 protein. We again performed coIP assays
with V5 antibody (similar assay as in Figure 7E). Less hVAP
MSP is recovered when EphrinB2 protein is increased in a
dose-dependent manner (Figure 7H, top panel), showing that
EphrinB2 is able to outcompete hVAPB MSP for binding to
EphA4 (quantified in Figure 7I). In summary, these data
indicate that VAP MSP domains bind to the extracellular domain
of Eph receptors and that this binding influences Ephrin
interactions.
DISCUSSION
ALS is a disease caused by death of anterior horn motor neurons
in the spinal cord and neurons in motor cortex, after decades of
apparently normal development and function (Talbot and An-
sorge, 2006). Familial and sporadic ALS cases as well as mouse
models induced by overexpressing mutant SOD1 indicate that
all forms lead to intracellular cytoplasmic protein inclusions con-
taining ubiquitinated proteins (Basso et al., 2006; de Vrij et al.,
2004; Moore et al., 2005). In flies expressing P58S dVAP, we
find cytoplasmic inclusions and other key characteristics of
ALS. First, P58S dVAP protein induces ubiqutinated inclusions.
Second, the protein inclusions are associated with the ER and
appear to be electron-dense ER expansions. Third, several key
ER proteins colocalize with these inclusions. Finally, mutant
dVAP induces a UPR. These data show at least three importantCell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc. 971
Figure 6. VAPs Have Extracellular Signaling Activity and Act in Common Genetic Pathways with Eph Receptors
(A and B) VAP MSP domains have extracellular signaling activity. (A) Microinjection is used to test molecules for the ability to induce oocyte (Oo) maturation and
sheath contraction in unmated fog-2(q71) females, which lack sperm. Injected solutions diffuse into the spermatheca (Sp) and proximal gonad (PG).
(B) Microinjections of purified, recombinant MSP domains are compared to a buffer-alone control injection. Additional negative controls are described in Miller
et al., 2001, 2003 and Corrigan et al., 2005. Oocyte maturations per hour and basal sheath contractions per minute were scored. Number of gonads is to the right
of SEM bars. *, p < 0.01; **, p < 0.001.
(C) VPR-1 encodes the sole VAP homolog in the C. elegans genome. The tm1411 allele deletes the translational start site and the MSP domain.
(D) Western analysis of mixed stage wild-type (W) and vpr-1 (tm1411) mutant (M) worms using antibodies against Drosophila VAP (Rb 92).
(E) Distal-tip cell (DTC) migration paths (black lines) in wild-type and mutant hermaphrodites. vpr-1 (tm1411) and vab-1 (dx31) null mutants have incompletely
penetrant and variably expressed defects in DTC migration (also see Figure S7A). vpr-1 (tm1411); vab-1 (dx31) double mutants exhibit the same defects as
vpr-1 (tm1411) single mutants. Bars, 20 mm.
(F) Amphid neuron positions in wild-type and mutant hermaphrodites. Amphid neurons (AN, diagram) migrate in an anterior to posterior direction during embryo-
genesis. Amphid cell body positions are shown by arrowheads. Loss of vab-1 partially suppresses the posterior positioning defect of vpr-1 (tm1411) mutants,972 Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc.
parallels with ALS and SOD1 mouse models: cytoplasmic inclu-
sions, ubiquitination, and the UPR. The UPR-induced stress
caused by P58S dVAP could eventually result in cellular damage
or neuronal death (Chai et al., 2008).
Another feature associated with ALS is that the disease may
have a cell-non-autonomous component. We show that VAP
MSP domains can be secreted, although not all cell types appear
capable of secretion in flies (Figure 2). The VAP proteins, includ-
ing the yeast homolog SCS2, have been proposed to be type II-
membrane proteins (Kagiwada et al., 1998). Since the proteins
lack an N-terminal signal sequence, similar to MSP, secretion
is likely to occur by an unconventional mechanism as observed
for the C.elegans MSP proteins (Kosinski et al., 2005). In addi-
tion, the hVAP MSP domain is present in blood serum, a finding
also supported by a large survey of serum proteins identified us-
ing mass spectrometry (Omenn et al., 2005). The MSP in serum
may be able to bind to Eph receptors present on endothelial
cells, which regulate angiogenesis (Kuijper et al., 2007). Indeed,
SOD1 mutants display defects in the tight junctions between
endothelial cells, and endothelial damage occurs prior to motor
neuron degeneration (Zhong et al., 2008). Interestingly, Teuling
et al. (2007) recently reported that VAPB is significantly
decreased in the spinal cord of SOD1 mutants and human
patients with sporadic ALS. It is therefore possible that reduced
signaling by the hVAP MSP domain is a mechanism responsible
for some nonautonomous features associated with ALS patho-
genesis.
Our results show that secreted MSP domains bind to Eph re-
ceptors on the surfaces of cells. Eph receptors also bind to li-
gands called Ephrins (Pasquale, 2005). MSP domains function
in vivo to antagonize Ephrin signaling during oocyte maturation
(Miller et al., 2003) and, possibly, amphid neuron migration.
Our competition assays are consistent with MSP domains com-
peting with Ephrin for Eph receptor binding (Figure 7). In other
processes, including worm-DTC cell migration, ovarian sheath
contraction, and fly MB formation, MSP domains seem to be re-
quired for Eph receptor signaling (Miller et al., 2003). Hence, the
relationship between MSP and Ephrin ligands to Eph receptor
signaling may depend on the developmental context, as previ-
ously observed for Ephrins and Eph receptors in mammals (Hi-
manen et al., 2007). Multiple Ephrins and Eph receptors including
EphA4 and A7 are expressed throughout the adult nervous sys-
tem and in skeletal muscle of vertebrate species (Iwamasa et al.,
1999; Lai et al., 2001). Eph receptors regulate the survival of
cultured spinal cord motor neurons (Magal et al., 1996) and
influence proliferation and apoptosis in the adult mammalian
CNS (Ricard et al., 2006). VAP MSP may play a role in motor
neuron survival or muscle function through interactions with
Eph receptors.
Glutamate excitotoxicity is likely to play a role in the pathogen-
esis of ALS (Bruijn et al., 2004). Three lines of evidence suggest
that VAP MSP domains might regulate glutamate receptor sig-
naling. First, Eph receptors directly associate with NMDA-sub-type glutamate receptors and regulate clustering in cultured
neurons (Dalva et al., 2000). Second, loss of dVAP function or
overexpression of P58S in flies is associated with increased glu-
tamate receptor clustering and increased amplitudes of mEJPs
at the NMJs (Chai et al., 2008; this work). Finally, MSP and the
VAB-1 Eph receptor regulate NMDA receptor function during
worm oocyte maturation (Corrigan et al., 2005).
We propose the following model for the pathogenesis of ALS8.
The P56S hVAP protein accumulates in the ER, while the wild-
type protein is functional. In time, the aggregates become
more prominent, P56S hVAP becomes ubiquitinated, and func-
tional wild-type proteins become trapped in the inclusions.
These protein inclusions initiate a UPR that eventually affects
cell viability and lead to a decrease in MSP domain secretion. Im-
paired secretion decreases signaling by Eph receptors and other
receptors. The mutant protein therefore causes two different de-
fects: a cell-autonomous defect in the ER that creates a UPR and
a cell non-autonomous defect resulting from reduced secretion
of VAP MSP, which may function as an autocrine or paracrine
signal. Both defects may synergize to produce the key features
of ALS pathology. This model provides testable hypotheses
and raises questions to be addressed in the future.
EXPERIMENTAL PROCEDURES
Fly Transgenes and Strains
The PCR fragment of theDrosophila EST clone (LD30122) containing the dVAP
coding sequence was subcloned into pUAST to generate UAS-dVAP. UAS-
P58S dVAP was created by chimeric PCR with primers containing a P58S mu-
tation. UAS-FLAG-dVAP-HA was created by chimeric PCR to add three FLAG
tags and two HA tags at the N terminus and C terminus of the dVAP protein,
respectively. UAS-hVAP was created by subcloning the coding sequence of
hVAPB into the pUAST vector.
For the strains used in this study, see Supplemental Data.
Antibody Generation and Immunostaining
For dVAP antibody production and the list of the antibodies used in the study,
see the Supplemental Data. Extracellular staining was performed as previously
described (Seto and Bellen, 2006).
Protein Chemistry
VAP MSP and Eph Receptor Binding Assays
293T cells were transfected with the pcVAB-1Ex-V5His or pcEphA4Ex-V5His
and incubated in OPTI-MEM (Invitrogen) for 2 days. The conditioned medium
was collected, and the Eph receptor extracellular domain proteins were puri-
fied on Ni beads. The bacterially expressed His-tagged VAP MSP proteins
(FLAG-VPR-1MSP or hVAPMSP) were also purified with Ni beads. After de-
salting, Eph receptor extracellular domain protein and VAP MSP protein
were incubated with each other in the binding buffer (50 mM Tris [pH 8.0],
100 mM NaCl, 10% glycerol, 0.1% NP40, protease inhibitor cocktail) for
30 min at 25C. The binding complexes were precipitated with anti-V5 (to
pull down Eph receptor) or anti-FLAG (to pull down VPR-1MSP) antibody.
The resulting precipitates were analyzed by western blotting with anti-V5,
anti-FLAG, or anti-His antibodies. To confirm the in vitro binding specificity be-
tween Eph A4 extracellular domain and hVAPMSP, the bacterially expressed
His-tagged Ephrin B2 protein was incubated together with EphA4Ex-V5His
and His-hVAPMSP. The binding complexes were immunoprecipitated withalthough the double mutants have positioning and nerve ring (NR) defects not observed in either single mutant. The terminal bulb (TB) is outlined in yellow. Bars,
20 mm.
(G) Head neuron positions in wild-type and vpr-1 (tm1411) hermaphrodites. A pan-neuronal transgenic reporter shows that many head neurons are positioned too
far posteriorly in vpr-1 (tm1411) mutants. Bars, 20 mm.Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc. 973
Figure 7. VAP MSP Domains Bind to Eph Receptor Extracellular Domains
(A) Diagram of the C. elegans proximal gonad. MSP binds to receptors on the oocyte (Oo) and sheath cell surfaces in the proximal gonad (Miller et al., 2003;
Corrigan et al., 2005).
(B) Receptor binding sites are visualized using FITC-conjugated MSP domains. FITC conjugates are biologically active in promoting oocyte maturation and
sheath contraction (Miller et al., 2003; data not shown). Compete includes a 25-fold molar excess of unlabeled protein. Bar, 20 mm.
(C and D) VPR-1 MSP domain can bind to VAB-1 Eph receptor. Purified FLAG-tagged VPR-1 MSP (VPR-1MSP-FLAG) and V5-tagged VAB-1 ECT domain (VAB-1
Ex-V5) were coimmunoprecipitated using FLAG antibody (C) and V5 antibody (D). IP, immunoprecipitation.
(E) His- and V5-tagged mouse EphA4 ectodomain (mEphA4Ex-V5His) and a His-tagged hVAPB MSP (hVAPMSP-His) coimmunoprecipitate using anti-V5
antibody.
(F) Conditioned medium containing hVAPMSP disrupts the interaction between mouse EphrinB2 (mEphrinB2) and EphA4. WCL: whole cell lysates.
(G) Quantification of the fraction of IP of (F). Lanes 1–4 correspond to the lanes in (F). Error bars represent SD.
(H) Ephrin B2 competes with hVAPB MSP for binding of EphA4 in a dose-dependent manner. As decreasing amounts of EphrinB2 are added, increasing amounts
of hVAP MSP are pulled down by mEphA4Ex-V5 His. Note that EphrinB2-His cannot be detected in the top panel because it has a similar molecular weight to the
IgG light chain. * shows nonspecific heavy and light chains of IgG.
(I) The quantification of the fraction of IP of (H). The lanes correspond to the lanes 1–4 in (H). Error bars represent SD.974 Cell 133, 963–977, June 13, 2008 ª2008 Elsevier Inc.
anti-V5 antibody and probed with anti-His antibody on western blot. For
quantification, the western blot results of three independent experiments
were scanned and analyzed by Image J. The binding affinity was indicated
by the averaged ratio of pull down to input. The standard deviation is indicated
by error bars.
For the constructs of the binding assays, protein fractionation, immunopre-
cipitation, serum purification, and the list of the antibodies, see Supplemental
Data.
C. Elegans Experiments
Culture and genetic manipulations were carried out at 20C as previously de-
scribed, except that NA22 bacteria were used as the food source instead of the
OP50 strain (Brenner, 1974). N2 is the wild-type strain. vpr-1 (tm1411) mutants
were obtained from the Japanese Bioresource Project and backcrossed to the
wild-type five times. tm1411 is a maternal effect sterile mutation. Microinjec-
tions, oocyte maturation and sheath contraction rate measurements, and
FITC binding assays were performed as previously described (Corrigan
et al., 2005). The amphid sensory neurons were labeled with the vital dye DiI
(Zallen et al., 1998). DTC migration paths were visualized in L3 to young adult
animals using the lag-2::GFP reporter, which expresses GFP in the DTC (Blel-
loch et al., 1999), DAPI staining, and DIC microscopy. For vpr-1 strain con-
struction, marker scoring, rescue experiment, the genetic strains used, and
4D video microscopy, see Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include seven figures, Supplemental Experimental Proce-
dures, and Supplemental References and can be found online at http://www.
cell.com/cgi/content/full/133/6/963/DC1/.
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